Company Update TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Press Release / Media Release BSE India Torrent Pharma enters into an agreement with Boehringer Ingelheim to acquire 3 anti-diabetes brands